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Robotripping: The Dangers of Abusing Dextromethorphan 
Discussion 
At very high dosages, DXM can cause agitation, violent  
behavior, liver damage, addiction, hallucinations, and  
delusions. Effects can be worsened with co-ingestions of  
other drugs, especially SSRIs, alcohol or opioids. 
Monitor for serotonin syndrome. Labs may show  
transaminitis and acute kidney injury. Treatment includes  
activated charcoal if ingestion is within 1 hour,  
respiratory support, IVFs, and benzodiazepines. 
Introduction 
Dextromethorphan (3-methoxy-N-methylmorphinan),  
also known as “DXM,” is a synthetically produced  
drug available in many over-the- counter (OTC)  
cough and cold medications as a centrally acting  
cough suppressant that binds to NMDA receptors. In  
a 2006 national survey of 50,000 students, 4, 5, and  
7% of 8, 10, and 12th graders reported DXM abuse  
in the past yearn [1]. In high doses, DXM can cause  
euphoria, hallucinations, dissociations, and distortion  
of cognition and perception [3]. DXM abuse is also  
known as “Robotripping,” “Robodosing,” “Dexing,”  
“Tussin,” or “Triple Cs” because Robitussin and  
Coricidin Cough and Cold are most frequently  
abused. DXM has replaced codeine and  
promethazine in many cough syrup preparations, yet  
it is still known as “Purple drank,” “Lean,” “Sizzurp,”  
“Orange Crush,” or “Skittles” when mixed with  
alcohol or soda for flavor. Co-toxicity can occur since  
DXM is usually combined with acetaminophen,  
antihistamines, or decongestants like  
pseudoephedrine. DXM reaches its peak effects at  
30-60 minutes, and lasts 2-4 hours [2]. Abusers often  
use throughout the day to maintain a consistent high.  
At doses of >500mg, users can experience  
hallucinations, violent behaviors, and even trance-  
like states [3]. Poison control recommends ED  
evaluation for ingestions of more than 7.5 mg/kg [1].  
We report an interesting case of DXM abuse whose  
symptoms present as acute psychosis. 
Case Report 
- 46 yo male history of depression, schizoaffective,  
bipolar disorder, was brought by EMS in restraints for  
AMS. He has numerous lacerations on chin and  
lower extremities. He is hyperactive, difficult to  
redirect, following simple commands, and appears to  
be responding to internal stimuli. He denies SI/HI. 
- Wife reports an empty bottle (237 ml) of Rite Aid  
Tussin Cough and Congestion medication containing  
20 mg of Dextromethorphan per 10 cc syrup. Non-  
compliant with psych meds and has had increasing  
religious delusions in the past few days. 
- Initial VS 101.8F, HR 138, RR 20, 145/77, 97% on  
RA. WBC 20. Lactate 1.8. BMP 133/4.5/105/10 /9 / 
1.55 < 136. AST/ALT 75/54. Neg UDS and UA. CK  
759. Etoh, salicylate, acetaminophen negative. 
- We discussed the case with Poison Control and  
provided supportive care for his suspected DXM  
overdose including Lorazepam for his agitation. He  
met sepsis criteria so covered him empirically with  
Ceftriaxone/Doxycycline for suspected aspiration  
pneumonia seen on CTAP. AKI improved after fluids.  
Transaminitis improved. 
- During his course, patient’s substance-abuse related  
psychosis improved. Patient admitted to abusing  
DXM 2-3 times a day for 2 weeks because it “gives  
him energy” to read. He recalls cutting himself with  
knife to “prove his dedication to God”. 
- His home medications were restarted including  
Aripiprazole, Buproprion, Fluoxetine, Ziprasidone,  
Clonazepam. Patient returned to baseline mentation. 
Conclusion 
DXM is an inexpensive OTC medication that is  
easily abused for its euphoric properties and can  
present to ED as altered mental status. Adverse  
drug effects include thermodysregulation, hypoxia,  
blurred vision, syncope, respiratory depression. 
DXM is known as “the poor man’s PCP” because  
intoxication can manifest as extreme agitation,  
violent behavior, and florid hallucinations. Do not  
delay call to Poison Control and be wary of  
fulminant hepatic failure. Supportive care is the 
mainstay of therapy. 
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Stages of  
intoxication  
by dose 
Side effects of Dextromethorphan  
(DXM) toxicity [3] 
1st plateau:  
100-200 mg 
• Effects similar to ecstasy 
•  Mild stimulation, uplifting effect 
• More energetic, social talkative 
2nd plateau:  
200-400 mg 
• Effects similar to alcohol intoxication 
• Decrease in motor and cognitive  
function, HTN, slurred speech 
• Euphoria and hallucination 
3rd plateau:  
400-600 mg 
• Effects similar to ketamine 
• Strong dissociation, intense  
hallucinations, loss of motor  
coordination, generalized weakness 
4th plateau:  
500-1500 mg 
• Effects similar to PCP 
• Effects can last up to 2 weeks 
• Trance-like state, out of body  
experience, delirium, hallucinations 
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